Neuropathic pain arises directly from a lesion or disease affecting the somatosensory system. Our current knowledge on the mechanisms of neuropathic pain comes largely from animal models of ...

Injuries to the somatosensory system may give rise to neuropathic pain. Injuries can occur at any interval along the neuraxis, but the most common locations are the peripheral and dorsal root ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...